Literature DB >> 30549495

What Should a Psychiatrist Know About Genetics? Review and Recommendations From the Residency Education Committee of the International Society of Psychiatric Genetics.

John I Nurnberger1,2, Jehannine Austin3, Wade H Berrettini4, Aaron D Besterman5, Lynn E DeLisi6, Dorothy E Grice7, James L Kennedy8, Daniel Moreno-De-Luca9, James B Potash10, David A Ross11, Thomas G Schulze12, Gwyneth Zai8.   

Abstract

The International Society of Psychiatric Genetics (ISPG) created a Residency Education Committee with the purpose of identifying key genetic knowledge that should be taught in psychiatric training programs. Thirteen committee members were appointed by the ISPG Board of Directors, based on varied training, expertise, gender, and national origin. The Committee has met quarterly for the past 2 years, with periodic reports to the Board and to the members of the Society. The information summarized includes the existing literature in the field of psychiatric genetics and the output of ongoing large genomics consortia. An outline of clinically relevant areas of genetic knowledge was developed, circulated, and approved. This document was expanded and annotated with appropriate references, and the manuscript was developed. Specific information regarding the contribution of common and rare genetic variants to major psychiatric disorders and treatment response is now available. Current challenges include the following: (1) Genetic testing is recommended in the evaluation of autism and intellectual disability, but its use is limited in current clinical practice. (2) Commercial pharmacogenomic testing is widely available, but its utility has not yet been clearly established. (3) Other methods, such as whole exome and whole genome sequencing, will soon be clinically applicable. The need for informed genetic counseling in psychiatry is greater than ever before, knowledge in the field is rapidly growing, and genetic education should become an integral part of psychiatric training. © Copyright 2018 Physicians Postgraduate Press, Inc.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30549495      PMCID: PMC6480395          DOI: 10.4088/JCP.17nr12046

Source DB:  PubMed          Journal:  J Clin Psychiatry        ISSN: 0160-6689            Impact factor:   4.384


  19 in total

1.  The Care of Patients With Complex Mood Disorders.

Authors:  Zachary A Cordner; Dean F MacKinnon; J Raymond DePaulo
Journal:  Focus (Am Psychiatr Publ)       Date:  2020-04-23

Review 2.  International Society of Psychiatric Genetics Ethics Committee: Issues facing us.

Authors:  Gabriel Lázaro-Muñoz; Maya Sabatello; Laura Huckins; Holly Peay; Franziska Degenhardt; Bettina Meiser; Todd Lencz; Takahiro Soda; Anna Docherty; David Crepaz-Keay; Jehannine Austin; Roseann E Peterson; Lea K Davis
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2019-05-23       Impact factor: 3.568

3.  Dr Nurnberger and Colleagues Reply.

Authors:  John I Nurnberger; Jehannine Austin; Wade H Berrettini; Aaron D Besterman; Lynn E DeLisi; Dorothy E Grice; James L Kennedy; Daniel Moreno-De-Luca; James B Potash; David A Ross; Thomas G Schulze; Gwyneth Zai
Journal:  J Clin Psychiatry       Date:  2019-04-09       Impact factor: 4.384

Review 4.  Gene-drug pairings for antidepressants and antipsychotics: level of evidence and clinical application.

Authors:  Lara E Murphy; Trehani M Fonseka; Chad A Bousman; Daniel J Müller
Journal:  Mol Psychiatry       Date:  2021-11-09       Impact factor: 15.992

Review 5.  Genes To Mental Health (G2MH): A Framework to Map the Combined Effects of Rare and Common Variants on Dimensions of Cognition and Psychopathology.

Authors:  Sébastien Jacquemont; Guillaume Huguet; Marieke Klein; Samuel J R A Chawner; Kirsten A Donald; Marianne B M van den Bree; Jonathan Sebat; David H Ledbetter; John N Constantino; Rachel K Earl; Donna M McDonald-McGinn; Therese van Amelsvoort; Ann Swillen; Anne H O'Donnell-Luria; David C Glahn; Laura Almasy; Evan E Eichler; Stephen W Scherer; Elise Robinson; Anne S Bassett; Christa Lese Martin; Brenda Finucane; Jacob A S Vorstman; Carrie E Bearden; Raquel E Gur
Journal:  Am J Psychiatry       Date:  2022-03       Impact factor: 19.242

Review 6.  Diagnostic genetic testing for neurodevelopmental psychiatric disorders: closing the gap between recommendation and clinical implementation.

Authors:  Brenda M Finucane; David H Ledbetter; Jacob As Vorstman
Journal:  Curr Opin Genet Dev       Date:  2021-01-09       Impact factor: 5.578

7.  In-vivo design feedback and perceived utility of a genetically-informed smoking risk tool among current smokers in the community.

Authors:  Jessica L Bourdon; Amelia Dorsey; Maia Zalik; Amanda Pietka; Patricia Salyer; Michael J Bray; Laura J Bierut; Alex T Ramsey
Journal:  BMC Med Genomics       Date:  2021-05-26       Impact factor: 3.063

8.  Using polygenic scores for identifying individuals at increased risk of substance use disorders in clinical and population samples.

Authors:  Peter B Barr; Albert Ksinan; Jinni Su; Emma C Johnson; Jacquelyn L Meyers; Leah Wetherill; Antti Latvala; Fazil Aliev; Grace Chan; Samuel Kuperman; John Nurnberger; Chella Kamarajan; Andrey Anokhin; Arpana Agrawal; Richard J Rose; Howard J Edenberg; Marc Schuckit; Jaakko Kaprio; Danielle M Dick
Journal:  Transl Psychiatry       Date:  2020-06-18       Impact factor: 6.222

9.  Assessing Stakeholder Perceptions of the Utility of Genetic Information for the Clinical Care of Mental Health Disorders: We Have a Will but Need to See the Way.

Authors:  Jessica L Bourdon; John M Hettema; Elizabeth C Prom-Wormley; Michael A Southam-Gerow
Journal:  Adm Policy Ment Health       Date:  2021-03

10.  Increasing the Clinical Psychiatric Knowledge Base About Pathogenic Copy Number Variation.

Authors:  Patrick F Sullivan; Michael J Owen
Journal:  Am J Psychiatry       Date:  2020-03-01       Impact factor: 18.112

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.